GENES DIS 润色咨询

Genes & Diseases

出版年份：暂无数据 年文章数：481 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2022-10-22 ZNB

    投稿一个多月 还是submit to journal

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2020-09-09 zhlf1989513

    审稿速度:3.0
    经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2022-06-28 ms7000001471703686

    偏重的研究方向：肿瘤;癌症生物学
    经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？

    8

    展开8条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2023-02-17 特立独行的兔子

    请问接受影像类的文章吗？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2022-03-06 ms8000001344402965

    这杂志是真的慢，一个星期了连mauscript number都没有

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2022-10-14 ms3000001252313498

    审稿速度:24.0 | 投稿命中率:25.0
    经验分享：了解一下

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2022-10-14 ms3000001252313498

    审稿速度:24.0 | 投稿命中率:5.0
    经验分享：了解中

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2022-10-04 ms9000001982912997

    期待涨到10分以上

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2022-09-12 ms7000001423716004

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向：糖尿病视网膜病变
    经验分享：审了俩个多月拒了，就一个审稿人

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883819, encodeId=219488381999, content=审稿速度:3.0<br>经验分享：审了三个月了，还没消息，发邮件咨询也不回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfd588208, createdName=zhlf1989513, createdTime=Wed Sep 09 10:59:44 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229228, encodeId=710b122922857, content=偏重的研究方向：肿瘤;癌症生物学<br>经验分享：各位前辈，请教一下，under review一个月后变成decision in process是拒稿信号吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c968191514, createdName=ms7000001471703686, createdTime=Tue Jun 28 18:25:01 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115040, encodeId=13892115040dc, content=请问接受影像类的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Feb 17 09:01:09 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199903, encodeId=d712119990348, content=这杂志是真的慢，一个星期了连mauscript number都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91db5601102, createdName=ms8000001344402965, createdTime=Sun Mar 06 14:40:28 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093707, encodeId=8e4e2093e07e1, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享：了解一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:09:56 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093706, encodeId=87262093e06f7, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：了解中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d8c6450563, createdName=ms3000001252313498, createdTime=Fri Oct 14 01:08:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091797, encodeId=d8f62091e9744, content=期待涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bda35414315, createdName=ms9000001982912997, createdTime=Tue Oct 04 21:28:50 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248496, encodeId=f13f12484964b, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：糖尿病视网膜病变<br>经验分享：审了俩个多月拒了，就一个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=185f8154331, createdName=ms7000001423716004, createdTime=Mon Sep 12 13:02:30 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227089, encodeId=fe42122e0899e, content=审稿人家意见还是很到位的，应该会越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85cc8142874, createdName=ms4000001484812236, createdTime=Fri Jun 17 21:07:19 CST 2022, time=2022-06-17, status=1, ipAttribution=)]
    2022-06-17 ms4000001484812236

    审稿人家意见还是很到位的，应该会越来越好

    1

    展开1条回复
共157条页码: 3/16页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分